The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of PI3K-α enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with PI3K-α signaling with the compounds and compositions of the disclosure.
本公开涉及新颖化合物及其制药组合物,以及利用本公开的化合物和组合物抑制
PI3K-α酶活性的方法。本公开进一步涉及但不限于利用本公开的化合物和组合物治疗与
PI3K-α信号相关的疾病的方法。